Genetics of type 1 von Willebrand disease

Anne Goodeve1

  • 1Academic Unit of Haematology, University of Sheffield, Sheffield, UK. a.goodeve@shef.ac.uk

Insights

Type 1 von Willebrand disease (VWD) genetics are complex. Some patients have von Willebrand factor gene mutations, while others have blood group O, suggesting multiple genetic factors contribute to VWD.

Area of Science:

  • Hematology
  • Genetics
  • Molecular Biology

Background:

  • Type 1 von Willebrand disease (VWD) is the most common form of VWD.
  • It has historically been the least understood subtype.
  • Recent research is clarifying its genetic underpinnings.

Purpose of the Study:

  • To review recent analyses of the genetic basis of Type 1 VWD.
  • To summarize current understanding of VWD genetics.

Main Methods:

  • Review of recent genetic analyses.
  • Linkage analysis in Type 1 VWD families.
  • Candidate gene mutation analysis of the von Willebrand factor (VWF) gene.

Main Results:

  • Approximately 50% of Type 1 VWD families show dominantly inherited, fully penetrant VWD.
  • 55-70% of index cases have a candidate VWF gene mutation; missense mutations are most common.
  • Blood group O is more prevalent in Type 1 VWD, especially in cases with incomplete penetrance or no VWF mutation.

Conclusions:

  • Type 1 VWD can be categorized into three groups based on genetic factors.
  • Group 1: Fully penetrant VWF mutations explain low VWF and bleeding.
  • Group 2: VWF mutations may interact with blood group O and other factors.
  • Group 3: VWF mutations are absent, but VWF may still play a role, with blood group O being common.
Abstract

Related Concept Videos

Incomplete Dominance01:43

Incomplete Dominance

Gregor Mendel's work (1822 - 1884) was primarily focused on pea plants. Through his initial experiments, he determined that every gene in a diploid cell has two variants called alleles inherited from each parent. He suggested that amongst these two alleles, one allele is dominant in character and the other recessive. The combination of alleles determines the phenotype of a gene in an organism.
Principles of Pharmacogenetics: Types of Genetic Variants01:27

Principles of Pharmacogenetics: Types of Genetic Variants

The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Blood Types02:20

Blood Types

Human blood is classified into different types based on the presence of antigens on the red blood cell's surface and antibodies in the plasma. Proper identification of blood type is essential for successful blood transfusion. The International Society of Blood Transfusion has identified 38 human blood types based on the surface antigens on the red blood cells. The most common types are ABO, Rh, and MNS blood types.
ABO blood group
ABO antigens are glycoproteins encoded by genes present on...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
Pedigree Analysis01:35

Pedigree Analysis

Overview